Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	60.47	44.66	27.33	20.44	28.22	16.7
Cash & Short-Term Investments	60.47	44.66	27.33	20.44	28.22	16.7
Cash Growth	116.87%	63.44%	33.68%	-27.56%	69.01%	-11.24%
Accounts Receivable	9.66	7.77	5.23	8.48	5.23	2.69
Inventory	14.41	9.19	14.53	14.68	13.6	11.68
Other Current Assets	2.14	2.48	2.45	2.97	1.86	1.15
Total Current Assets	86.68	64.1	49.53	46.57	48.91	32.22
Net Property, Plant & Equipment	4.16	3.45	4.54	6.32	7.36	4.43
Other Intangible Assets	0.28	0.36	0.51	0.67	0.86	1.08
Other Long-Term Assets	0.41	0.37	0.38	0.5	0.72	0.63
Total Assets	91.53	68.28	54.96	54.06	57.84	38.36
Accounts Payable	13.68	8.53	10.23	9.68	10.42	9.45
Accrued Expenses	7.38	7.82	9.49	7.34	6.48	6.13
Current Portion of Leases	0.96	0.99	0.7	0.7	0.55	0.62
Unearned Revenue	0.3	0.61	0.2	0.16	0.16	0.28
Total Current Liabilities	22.33	17.95	20.62	17.87	17.61	16.48
Long-Term Leases	2.33	1.66	2.58	3.56	4.15	1.02
Other Long-Term Liabilities	2.67	2.58	3.31	3.96	4.35	4.44
Total Long-Term Liabilities	5	4.24	5.89	7.52	8.5	5.46
Total Liabilities	27.33	22.18	26.51	25.39	26.11	21.93
Common Stock	0.08	0.08	0.08	0.07	0.07	0.06
Additional Paid-in Capital	237.36	227.93	218.85	214.09	200.61	158.19
Accumulated Other Comprehensive Income	-0	-0	-0	-0	-0	-0
Retained Earnings	-173.24	-181.91	-190.46	-185.49	-168.95	-141.83
Shareholders' Equity	64.2	46.09	28.46	28.67	31.73	16.42
Total Liabilities & Equity	91.53	68.28	54.96	54.06	57.84	38.36
Total Debt	3.29	2.65	3.28	4.26	4.7	1.64
Net Cash (Debt)	57.18	42.01	24.05	16.18	23.52	15.06
Net Cash Growth	36.12%	74.69%	48.59%	-31.18%	56.16%	-11.89%
Net Cash Per Share	0.69	0.54	0.32	0.23	0.35	0.25
Book Value	64.2	46.09	28.46	28.67	31.73	16.42
Book Value Per Share	0.78	0.59	0.38	0.41	0.47	0.27
Tangible Book Value	63.91	45.74	27.95	28	30.87	15.34
Tangible Book Value Per Share	0.77	0.59	0.37	0.40	0.46	0.25

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q